Extracellular vesicles (EVs) are biocompatible, nano-sized secreted vesicles containing many types of biomolecules, including proteins, RNAs, DNAs, lipids, and metabolites. Their low immunogenicity and ability to functionally modify recipient cells by transferring diverse bioactive constituents make them an excellent candidate for a next-generation drug delivery system. Here, the recent advances in EV biology and emerging strategies of EV bioengineering are summarized, and the prospects for clinical translation of bioengineered EVs and the challenges to be overcome are discussed.
CITATION STYLE
Teng, F., & Fussenegger, M. (2021, January 1). Shedding Light on Extracellular Vesicle Biogenesis and Bioengineering. Advanced Science. John Wiley and Sons Inc. https://doi.org/10.1002/advs.202003505
Mendeley helps you to discover research relevant for your work.